Confronting the Obesity and Diabetes Epidemics

Economic and Epidemiologic Burden

• Chronic diseases in the U.S. incur total economic costs of $3.4 trillion (19.6% of GDP), comprising $1.1 trillion in direct healthcare costs and $2.3 trillion in indirect productivity losses.
• Obesity is the single largest contributor to the chronic disease burden, accounting for 47% of total chronic disease costs.
• The total economic impact of obesity is $1.57 trillion annually (8.5% of GDP), broken down into $419 billion in direct healthcare costs and $1.15 trillion in indirect costs.
• Diabetes treatment costs are estimated at $190 billion in direct healthcare expenses, rising to nearly $500 billion when including productivity losses.
• Relative risk analysis indicates that adults with obesity are 3.4 times more likely to develop diabetes, 2 times more likely to develop Alzheimer's/vascular dementia, 1.6 times more likely to develop coronary heart disease, and 1.3 times more likely to develop congestive heart failure.
• Epidemiological data shows 93 million adults in the U.S. have obesity, 30 million have diagnosed diabetes, and 84 million are pre-diabetic.
• Prevalence of obesity and diabetes is significantly higher among underserved populations, including African Americans, Mexican Americans, and those living in poverty.

Clinical Delivery and Care Models

• A severe capacity crisis exists in primary care, with an estimated 90 patients having severe obesity (BMI ≥40) for every one primary care provider.
• Mark Hyman (Cleveland Clinic) reported a "food pharmacy" model (based on Geisinger) reduced average annual costs from $240,000 to $48,000 per patient (an 80% reduction) while reversing heart failure, kidney failure, and fatty liver in poorly controlled diabetics.
• A specific case study at Cleveland Clinic noted a patient reducing HbA1c from 11 to 5.4, reversing multiple organ failures, and losing 43 pounds via a 20-hour community-based lifestyle program supported by nutritionists and coaches.
• The "Daniel Plan," a faith-based functional medicine program in Cleveland, engaged 15,000 participants (turning away 2,000) and achieved a collective weight loss of 250,000 pounds in the first year.
• Community health workers were identified as the most effective intervention in a report on the $10 billion CMS Innovation Fund deployment.
• Cleveland Clinic has committed to reimagining care delivery beyond clinical walls through its new "Community Care" institute, aiming to hire 10,000 community health workers to address structural violence and social determinants of health.

Digital Health and Technology Solutions

• OnDuo (Josh Riff) and Omada (Sean Duffy) utilize telemedicine and digital platforms to democratize access to endocrinology and lifestyle coaching, addressing barriers of time, geography, and employment flexibility.
• Digital platforms are designed to meet users "where they are" (e.g., smartphones) to facilitate longitudinal engagement required for chronic disease management, which episodic clinic visits cannot support.
• Sean Duffy (Omada) highlighted that technology must pass a "Sean's mom test" (ease of use) for underserved populations, noting the abandonment of complex pairing (Wi-Fi/Bluetooth) in favor of SIM-enabled scales for elderly and low-literacy users.
• Omada holds 11 Medicaid contracts and is actively participating in CDC digital demonstration projects to prove efficacy and value in public payer populations.
• OnDuo reports that 40% of their users are over age 60, with seniors demonstrating some of the greatest clinical results, challenging the myth that older adults cannot use digital health tools.
• Sean Duffy noted that while 5-7% of people naturally adopt health programs, digital solutions must prove they reach the 10-15% of the population with the highest need to secure broader reimbursement.

Policy, Reimbursement, and Structural Barriers

• A primary barrier to scaling is reimbursement; current CDC Diabetes Prevention Program (DPP) and CMS benefits are shaped for in-person programs, excluding digital-only providers.
• Omada operates on an outcomes-based commercial model where they charge 100% only upon achieving weight loss outcomes, betting on data to shift reimbursement paradigms.
• CMS and payers express concern regarding "selection bias," fearing digital marketing naturally attracts motivated individuals rather than those with the greatest clinical need.
• Panelists argue the U.S. food system drives disease through subsidies: corn is heavily subsidized while fruits and vegetables receive only 1% of agricultural subsidies.
• Policy recommendations include implementing soda taxes (citing a 50% consumption reduction in Abu Dhabi after a 50% tax) and banning food marketing to children (citing Chile's success in reducing consumption).
• There is a consensus that "reimbursement-based medicine" has replaced "evidence-based medicine," preventing the adoption of proven lifestyle interventions despite their cost-effectiveness.
• Panelists advocate for shifting from a "sick care" model to a "health care" model, requiring value-based payments that reward prevention and community-based outcomes rather than episodic treatment.

Forward-Looking Statements and Strategic Priorities

• Sean Duffy (Omada) projects that within five years, Primary Care Providers will be able to seamlessly refer patients to digital prevention programs, provided commercial reimbursement expands to match private sector capabilities.
• Mark Hyman forecasts that the single most effective lever for behavioral change is changing the money flow by reimbursing "food as medicine" and community-based solutions.
• Kelly Close (Diatribe) and Bill Dietz emphasize that systemic change will likely originate at the community or state level rather than the federal level, requiring cross-sectoral initiatives to overcome political will.
• The panel agrees on the necessity of a multi-stakeholder approach involving government, philanthropy, big food companies, and employers to create an environment where healthy choices are the default.
• Josh Riff (OnDuo) advocates for a "push-pull" dynamic where consumer demand and corporate shifts (e.g., beverage companies launching health-forward drinks due to cognitive decline concerns) drive industry reform.
• Bill Dietz concludes that solving these pandemics requires viewing obesity and diabetes as medical problems rather than cosmetic issues, necessitating a shift in public perception and policy focus.